Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: Cluster randomised controlled trial

BMJ (Online)

Volumn 347, Issue 7930, 2013, Pages

  Priebe, Stefan ^a   Yeeles, Ksenija ^b   Bremner, Stephen ^c   Lauber, Christoph ^d   Eldridge, Sandra ^c   Ashby, Deborah ^e   David, Anthony S ^f   O'Connell, Nicola ^a   Forrest, Alexandra ^b   Burns, Tom ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d Services Psychiatriques   (Switzerland)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FINANCIAL INCENTIVE; HUMAN; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; MENTAL HEALTH SERVICE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REWARD; SCHIZOAFFECTIVE PSYCHOSIS; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; CLUSTER ANALYSIS; FEMALE; HUMANS; INCOME; MAINTENANCE CHEMOTHERAPY; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; PSYCHOTIC DISORDERS; REGRESSION ANALYSIS; REWARD; YOUNG ADULT;

EID: 84886631425     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f5847     Document Type: Article

References (40)

1. Novick D, Haro JM, Suarez D, Perez V, Dittmann RW, Haddad PM. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res 2010;176:109-13.
2. Conley RR, Kelly DL. Management of treatment resistance in schizophrenia. Biol Psychiatry 2001;50:898-911. (Pubitemid 34020701)
3. Knapp M, King D, Pugner K, Lapuerta P. Non-adherence to antipsychotic medication regimens: associations with resource use and costs. Br J Psychiatry 2004;184:509-16. (Pubitemid 38725711)
4. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions-scientific review. JAMA 2002;288:2868-79. (Pubitemid 35425073)
5. Nose M, Barbui C, Gray R, Tansella M. Clinical interventions for treatment non-adherence in psychosis: meta-analysis. Br J Psychiatry 2003;183:197-206. (Pubitemid 37070173)
6. Gray R, Leese M, Bindman J, Becker T, Burti L, David A, et al. Adherence therapy for people with schizophrenia. European multicentre randomised controlled trial. Br J Psychiatry 2006;189:508-14. (Pubitemid 44876869)
7. National Collaborating Centre for Mental Health. Schizophrenia: core interventions in the treatment and management of schizophrenia in adults in primary and secondary care (Update). CG82. March 2009 ed. National Institute for Health and Clinical Excellence, 2009:41.
8. Vieta E. Improving treatment adherence in bipolar disorder through psychoeducation. J Clin Psychiatry 2005;66(suppl 1):24-9. (Pubitemid 350042454)
9. Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ 1997;315:703-7. (Pubitemid 27405824)
10. Marteau TM, Ashcroft RE, Oliver A. Using financial incentives to achieve healthy behaviour. BMJ 2009;338:b1415.
11. Burton A, Marougka S, Priebe S. Do financial incentives increase treatment adherence in people with severe mental illness? A systematic review. Epidemiol Psichiatr Soc 2010;19:233-42.
12. Carey KB, Carey MP. Enhancing the treatment attendance of mentally ill chemical abusers. J Behav Ther Exp Psychiatry 1990;21:205-9.
13. Helmus TC, Saules KK, Schoener EP, Roll JM. Reinforcement of counseling attendance and alcohol abstinence in a community-based dual-diagnosis treatment program: a feasibility study. Psychol Addict Behav 2003;17:249-51. (Pubitemid 37153100)
14. Post EP, Cruz M, Harman J. Incentive payments for attendance at appointments for depression among low-income African Americans. Psychiatr Serv 2006;57:414-6. (Pubitemid 43364197)
15. Roll JM, Higgins ST, Steingard S, McGinley M. Use of monetary reinforcement to reduce the cigarette smoking of persons with schizophrenia: a feasibility study. Exp Clin Psychopharmacol 1998;6:157-61 (Pubitemid 28253075)
16. Roll JM, Chermack ST, Chudzynski JE. Investigating the use of contingency management in the treatment of cocaine abuse among individuals with schizophrenia: a feasibility study. Psychiatry Res 2004;125:61-4. (Pubitemid 38210253)
17. Shaner A, Roberts LJ, Eckman TA, Tucker DE, Tsuang JW, Wilkins JN, et al. Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv 1997;48:807-10. (Pubitemid 27232880)
18. Sigmon SC, Steingard S, Badger GJ, Anthony SL, Higgins ST. Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Exp Clin Psychopharmacol 2000;8:509-17.
19. Tidey JW, O'Neill SC, Higgins ST. Contingent monetary reinforcement of smoking reductions, with and without transdermal nicotine, in outpatients with schizophrenia. Exp Clin Psychopharmacol 2002;10:241-7. (Pubitemid 34919932)
20. Tracy K, Babuscio T, Nich C, Kiluk B, Carroll KM, Petry NM, et al. Contingency management to reduce substance use in individuals who are homeless with co-occurring psychiatric disorders. Am J Drug Alcohol Abuse 2007;33:253-8. (Pubitemid 46752593)
21. Olson RP, Greenber DJ. Effects of contingency-contracting and decision-making groups with chronic mental patients. J Consult Clin Psychol 1972;38:376-83.
22. Drebing CE, Van Ormer EA, Krebs C, Rosenheck R, Rounsaville B, Herz L, et al. The impact of enhanced incentives on vocational rehabilitation outcomes for dually diagnosed veterans. J Appl Behav Anal 2005;38:359-72. (Pubitemid 43592186)
23. Claassen D, Fakhoury WK, Ford R, Priebe S. Money for medication: financial incentives to improve medication adherence in assertive outreach. Psychol Bull 2007;31:4-7. (Pubitemid 46099168)
24. Tidey JW. Using incentives to reduce substance use and other health risk behaviors among people with serious mental illness. Prev Med 2012;55:S54-60.
25. Ries RK, Dyck DG, Short R, Srebnik D, Fisher A, Comtois KA. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness. Psychiatr Serv 2004;55:445-7. (Pubitemid 38445595)
26. Staring AB, Mulder CL, Priebe S. Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands. Psychopharmacol Bull 2010;43:5-10.
27. Wise J. NICE Citizens Council debates incentives for healthy behaviour. BMJ 2010;340:c2747.
28. Burns T. Is it acceptable for people to be paid to adhere to medication? Yes. BMJ 2007;335:232.
29. Shaw J. Is it acceptable for people to be paid to adhere to medication? No. BMJ 2007;335:233.
30. Cookson R. Should disadvantaged people be paid to take care of their health? Yes. BMJ 2008;337:a589.
31. Popay J. Should disadvantaged people be paid to take care of their health? No. BMJ 2008;337:a594.
32. Claassen D. Financial incentives for antipsychotic depot medication: ethical issues. J Med Ethics 2007;33:189-93.
33. Promberger M, Brown RC, Ashcroft RE, Marteau TM. Acceptability of financial incentives to improve health outcomes in UK and US samples. J Med Ethics 2011;37:682-7.
34. Priebe S, Sinclair J, Burton A, Marouqka S, Larsen J, Firn M, et al. Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: a focus group study. J Med Ethics 2010;36:463-8.
35. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research: WHO, 1993.
36. Guy W. National Institute of Mental Health (US). Psychopharmacology Research Branch. Division of Extramural Research Programs. ECDEU assessment manual for psychopharmacology. US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976.
37. Priebe S, McCabe R, Bullenkamp J, Hansson L, Lauber C, Martinez-Leal R, et al. Structured patient-clinician communication and 1-year outcome in community mental healthcare-cluster randomised controlled trial. Br J Psychiatry 2007;191:420-6. (Pubitemid 350069583)
38. Priebe S, Golden E, McCabe R, Reininghaus U. Patient-reported outcome data generated in a clinical intervention in community mental health care-psychometric properties. BMC Psychiatry 2012;12:113.
39. Glover GR, Leese M, McCrone P. More severe mental illness is more concentrated in deprived areas. Br J Psychiatry 1999;175:544-8.
40. Stata statistical 10.1 [program]. College Station, TX: StataCorp, 2009.